Category Archives: Health

Diet, disease, Health, Healthy eating

New study links people who don’t get enough sleep to poor nutrition

Leave a comment
Study links people who don’t get enough sleep to poor nutrition

Poor sleep has been connected to poor nutrition. However, it is unclear why the two may appear together. The association between the issues was revealed in a study that looked at National Health and Nutrition Examination Survey data, based on the American Society for Nutrition, which unearthed that individuals who sleep lower than seven hours per night might also lack adequate levels of vital nutrients.

Following the CDC, adults should get more than seven hours of sleep per night to maintain their health. The brand new study unearthed that US adults who got not as much as that number also, an average of, consumed fewer nutrients like vitamins D and A, zinc, niacin, and more.

Some vitamins and minerals are vital for health but are not created by the body. Someone with a poor diet could be with a lack of at least one of these micronutrients, eventually leading to disruption in normal bodily functions, or perhaps the introduction of diseases or any other problems.

As well as a connection between poor sleep and poor nutrition, the study found that more nutrients were connected to poor sleep in females; taking vitamin supplements reduced the amount, based on the study, hinting at a potential benefit from supplementing to fill the nutritional gaps in one’s diet.

The findings may be revealed because of the study’s lead author Chioma Ikonte in the annual American Society for Nutrition meeting. The type for the study means the researchers were not able to find out whether someone suffers poor sleep quality because of poor nutrition, or if perhaps poor sleep quality eventually results in nutritional deficits.

Reference

Study links people who don’t get enough sleep to poor …. https://www.slashgear.com/study-links-people-who-dont-get-enough-sleep-to-poor-nutrition-09579778/

disease, Health

It is interesting that body fat distribution linked to higher risk of aggressive prostate cancer

Leave a comment
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia

In the first prospective study of directly measured body fat distribution and prostate cancer risk, investigators unearthed that higher levels of abdominal and thigh fat are associated with an increased danger of aggressive prostate cancer. Published early online in a peer-reviewed journal associated with the American Cancer Society, the findings can result in a significantly better knowledge of the partnership between obesity and prostate cancer and supply new insights for treatment.

Previous research reports have shown that obesity is related to a heightened chance of advanced prostate cancer and a poorer prognosis after diagnosis. Also, emerging evidence shows that the precise distribution of fat in the torso may be an essential factor.

To offer high-quality evidence, Barbra Dickerman, Ph.D., associated with the Harvard T.H. Chan School of Public Health, along with her colleagues analyzed body fat distribution using the gold-standard way of measuring computed tomography imaging and assessed the possibility of being identified as having, and dying from, prostate cancer among 1,832 Icelandic men who were followed for up to 13 years.

Throughout the study, 172 men developed prostate cancer, and 31 died from the disease. The accumulation of fat in specific areas—such as visceral fat (deep in the abdomen, surrounding the organs) and thigh subcutaneous fat (just under the skin)—was associated aided by the threat of advanced and fatal prostate cancer. High body mass index (BMI) and high waist circumference were also connected with higher risks of advanced and fatal prostate cancer.

Interestingly, when looking separately at men with a high BMI versus low BMI, we discovered that the association between visceral fat and advanced and fatal prostate cancer was stronger among men with a lower BMI. The precision of these estimates was limited in this subgroup analysis, but this might be an intriguing signal for future research.

Additional studies are needed to investigate the role of fat distribution when looking at the development and progression of prostate cancer and exactly how alterations in fat stores as time passes may affect patients’ health. Ultimately, identifying the patterns of fat distribution, which are from the highest risk of clinically significant prostate cancer might help to elucidate the mechanisms linking obesity with aggressive disease and target men for intervention strategies.

An accompanying editorial notes that lifestyle interventions—such as diet and exercise—that target fat loss may also reduce the risk of prostate cancer.

Reference
Body fat distribution linked to higher risk of aggressive …. https://medicalxpress.com/news/2019-06-body-fat-linked-higher-aggressive.html

Can Fat Thighs Give You Cancer? Study Finds Link Certain …. https://uevf.org/cancer/fat-thighs-give-cancer-study-finds-link-kinds-obesity-aggressive-prostate-cancer-68666028

Diet, disease, Health

It is interesting that Vitamin D supplement does not prevent type 2 diabetes in adults at high risk, study finds

Leave a comment

Taking a daily vitamin D supplement will not prevent type 2 diabetes in adults at high risk, according to results from research funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an element of the National Institutes of Health. The Vitamin D and Type 2 Diabetes (D2d) study enrolled 2,423 adults and was conducted at 22 sites throughout the united states of America. These findings were published June 7 into the New England Journal of Medicine and presented during the 79th Scientific Sessions regarding the American Diabetes Association in San Francisco bay area.

2d may be the most extensive study to directly examine if daily vitamin D supplementation assists in maintaining people at high risk for type 2 diabetes from developing the illness. The analysis included adults aged 30 or older and assigned participants randomly to either take 4,000 International Units (IU) for the D3 (cholecalciferol) kind of vitamin D or a placebo pill daily. All study participants had their vitamin D levels measured at the beginning of the study. During those times, about 80% of participants had vitamin D levels considered sufficient by U.S. nutritional standards.

“Observational studies have reported an association between lower levels of vitamin D and increased risk for type 2 diabetes,” said Myrlene Staten, M.D., D2d project scientist at NIDDK. “Additionally, smaller studies discovered that vitamin D could improve the function of beta cells, which produce insulin. However, whether vitamin D supplementation might help prevent or delay type 2, diabetes had not been known.”

The analysis screened participants every three to half a year for an average of 2.5 years to ascertain if diabetes had developed. Researchers then compared how many people in all the two study groups which had progressed to type 2 diabetes. At the end of the analysis, 293 away from 1211 participants (24.2%) in the vitamin D group developed diabetes in comparison to 323 out of 1212 (26.7%) into the placebo group – a difference that failed to reach statistical significance. The study was made to detect a risk decrease by 25% or even more.

D2d enrolled a different number of participants with a variety of physical characteristics, including sex, age, and body mass index, as well as racial and ethnic diversity. This representation helps ensure that the analysis findings could be widely applicable to people at high risk for developing type 2 diabetes.

As well as the study’s size, certainly one of its major strengths could be the diversity of their participants, which enabled us to examine the effect of vitamin D across a sizable number of people. When the study ended, we found no meaningful difference between the two groups, no matter age, sex, race, or ethnicity.

Reference
NIH-funded trial finds vitamin D does not prevent type 2 …. https://www.nih.gov/news-events/news-releases/nih-funded-trial-finds-vitamin-d-does-not-prevent-type-2-diabetes-people-high-risk

disease, Health

Do you know in milestone trial, experimental drug delays type 1 diabetes?

Leave a comment

Marking the culmination of a 33-year odyssey, scientists today report a milestone in type 1 diabetes: the first occasion the illness happens to be markedly delayed in young adults at high risk. Presenting in the American Diabetes Association meeting in San Francisco and publishing simultaneously when looking at the New England Journal of Medicine, researchers found that two weeks of an experimental intravenous drug held off disease by on average about e of years.

The mainstay of type 1 diabetes treatment is insulin, discovered 97 years ago. These results open an innovative new chapter, says Jeffrey Bluestone, an immunologist at the University of California, San Francisco bay area, and the first research team. “On the only hand,” the outcome is “pretty exciting,” Bluestone says. “On one other hand, now the actual time and effort begin.” Which will mean considering just how to move this treatment forward and probing whom it is most very likely to help?

The clinical trial began eight years back and included 76 people, the youngest of whom were 8 yrs. old plus the oldest within their 40s. Nearly three-quarters were 18 and under. Each had an incredibly high danger of type 1 diabetes. In this autoimmune disease, the body attacks cells within the pancreas, which make insulin, which helps keep blood glucose levels under control. Because of the time diabetes is diagnosed, a lot of these insulin-producing cells, called beta cells, have left.

Reference
In milestone trial, experimental drug delays type 1 …. https://ehealthynews.com/2019/06/10/in-milestone-trial-experimental-drug-delays-type-1-diabetes-science-magazine/

Diet, disease, Health, Healthy eating

It is amazing that scientists dream of a personalized diet based on Genetics

Leave a comment

No single food regimen works well with everyone. New research is one of comprehensive effort yet to understand why.

CreditGetty Images

Photo by Pixabay on Pexels.com

A decade ago, spurred by the success of the Human Genome Project and the affordability of genetic sequencing, scientists started to explore the promise of “nutrigenomics.” Could personalized nutrition, informed by understanding of an individual’s DNA, assist in preventing and even
treat diet-related diseases?

The outcome of early studies from Harvard, Stanford and elsewhere were compelling: Genetic differences did actually predispose individuals to lose different levels of weight on different sorts of diets. A multimillion-dollar industry soon sprang up, premised on marketing DNA-based diets. But subsequent studies have failed to demonstrate any statistically significant difference between fat reduction between overweight individuals who “eat suitable for their genotype” and the ones that do not.

In fact, the result of genes on obesity has been hard to tease out; various studies put the figure at anywhere from 35 to 85 percent. Nutritionists have traditionally observed that no body weight-loss strategy works well with everyone, and that individuals show striking differences in their responses to different diets.

Reference
Diet for One? Scientists Stalk the Dream of Personalized …. https://monohealthy.com/diet-for-one-scientists-stalk-the-dream-of-personalized-nutrition-the-new-york-times/

Diet, disease, Health, Healthy eating

Chicken vs. Red Meat

Leave a comment

A new study mentioned that the prevalent belief that white meat, such as chicken, is healthier for cholesterol levels compared to red meat, such as beef, pork, or lamb.

Photo by Pixabay on Pexels.com

A new study suggests that eating poultry is just as bad for our cholesterol levels as eating red meat.

A new review breaks some bad update for meat eaters, as scholars discover that white meat is at this moment as detrimental to cholesterol as red meat.

The paper counters the extensive belief that white meat is further beneficial than red. This belief depends on a range of observational findings that have discovered a connection concerning red meat intake and a advanced danger of cardiovascular disease.

Reference

When it comes to cholesterol, is chicken as bad as red meat?. https://www.nbcnews.com/health/health-news/when-it-comes-cholesterol-chicken-bad-red-meat-n1013376

Diet, disease, Health

Blood pressure drugs may help reduce dementia risk

Leave a comment

A massive innovative analysis has discovered a connection concerning choosing many classes of blood pressure-lowering medications and a minor risk of dementia amongst senior adults, adding to the conversation about the relationship concerning cognitive deterioration and high blood pressure.

People who take blood pressure-lowering medication may have a lower risk of dementia.

Dementia is an umbrella term for numerous neurodegenerative disorders, the most extensive of which is Alzheimer’s disease.

The critical trait of dementia is progressive cognitive deterioration, in which a person encounters memory loss and degeneration in their reasoning and decision-making capabilities.

Scientists are still ambiguous as to what causes dementia, but in an attempt to progress prevention stratagems, they have been examining the possible danger causes that may be a factor to the progress of this condition.

Various current studies have connected hypertension with an advanced risk of dementia. For example, a paper that appeared in the journal Neurology last year found that hypertension is coupled to a higher risk of suffering brain lesions, which are, in turn, attached to dementia.

Reference

May | 2019 | My CMS | Page 40. https://www.medicationjunction.com/2019/05/page/40/



Health

Increasing exposure to laundry detergent packets among older children

Leave a comment

There was an average of 1 call about every 42 minutes in 2017 towards the poison control center linked to liquid laundry detergent packets.

The voluntary standard, public awareness campaigns of detergent packets poison, and product and packaging changes to-date are reasonable first steps. Nevertheless, the numbers are nevertheless unacceptably high.

The analysis authors claim that detergent makers reformulate the pods and create regular packaging, which makes them childproof.

There was an average of one call about every 42 minutes in 2017 into the poison control center linked to liquid laundry detergent packets.

The study authors declare that detergent makers reformulate the pods and make a standard packaging which makes them childproof.

Reference
Despite safety standard, laundry packet exposures increase …. https://www.eurekalert.org/pub_releases/2019-06/nch-dss053119.php

Diet, Health

Do you believe that drinking coffee, even 25 cups a day, not bad for the heart?

Leave a comment

A brand new study published Monday claims that coffee is not as bad for the human heart as formerly believed.

Researchers with the William Harvey Research Institute at the Queen Mary University of London replied they debunked prior studies that reported drinking coffee — even up to 25 cups a day — could stiffen arterial blood vessels.

Despite the huge popularity of coffee worldwide, different reports could put people off from taking pleasure in it. While we cannot show an irregular connection in this study, the research implies coffee is not as bad for the arteries as prior studies would suggest.

Evaluating more than 8,000 men and women in the United Kingdom, the research divided individuals into three groups dependant on their coffee intake. The research study did incorporate people who consumed up to 25 cups per day, the average quantity of coffee respondents drank was five cups per day.

Reference
Baltimore Jewish Life | Drinking Coffee, Even 25 Cups A …. https://baltimorejewishlife.com/news/news-detail.php?SECTION_ID=1&ARTICLE_ID=118967

disease, Health

It is amazing how drugs make headway against lung, breast, and prostate cancers

Leave a comment

Newer drugs are substantially improving and enhancing the chances of survival for some individuals with hard-to-treat forms of lung, breast, and prostate cancer, doctors, reported at the world’s largest cancer conference.

Photo by Pixabay on Pexels.com

Immunotherapy drugs such as Keytruda have transformed the various treating types of cancerous tumors, but they’re still relatively new and don’t help most patients. The most extensive study yet of Keytruda in patients with advanced lung cancer discovered that 23 percent of those who got the drug as an element of their initial therapy survived at least five years, whereas 16 percent of those who tried other treatments first did. The risk of this rises with age, but about 48,000 cases each in the U.S. are in women under age 50 years. About 70 percent are “hormone-positive, HER2-negative” — that is, cancer’s growth is fueled by estrogen or progesterone and not by the gene that the drug Herceptin targets.

In research of 672 women with such cancers that had spread or been very advanced, adding the Novartis drug Kisqali to the usual hormone blockers as initial therapy helped more than hormone treatment alone.

After 3½ years, 70 percent of females on Kisqali were alive, compared to 46 percent for the remainder. Side effects were more typical with Kisqali.

This is the very first time any treatment has boosted survival beyond what hormone blockers do for such patients.

The choices keep expanding for men with prostate cancer that has spread beyond the gland. Standard therapy is drugs that block the male hormone testosterone, which helps these cancers grow, plus chemotherapy or even a newer drug called Zytiga.

Now, two other drugs have proved to extend survival whenever used like chemo or Zytiga in guys who were getting natural hormone therapy and still being helped by it.

One study tested Xtandi, sold by Pfizer and Astellas Pharma Inc., in 1,125 guys, half of whom also were chemo that is getting. After three years, 80 % of those offered Xtandi plus standard treatments were alive, contrasted to 72 percent of men given the other treatments alone. The other research involved 1,052 guys who got hormone treatment with or minus the Janssen drug Erleada. After two years, success was 82 percent among those on Erleada and 74 percent those types of who wasn’t.

Men now have a range of four drugs that provide comparable benefits, with no studies yet have compared them against one another, said Dr. Ethan Basch, a prostate specialist at the University of North Carolina’s Lineberger Comprehensive Cancer Center who may have no financial ties to any drugmakers.

However, chemo can cause numbness and tingling in the tactile arms and feet and may even maybe not be suitable for men with diabetes who already are at higher risk because of this problem. Zytiga must be studied having a steroid; Xtandi and Erleada can cause fainting and falling.

Chemo has more side effects, but it costs much less and requires only four to six intravenous treatments. One other three medications are pills that cost more than $10,000 a month and tend to be taken indefinitely.

Reference
Drugs make headway against lung, breast, prostate cancers …. https://www.everyday-scoop.com/drugs-make-headway-against-lung-breast-prostate-cancers-the-associated-press/